Colon Cancer Risk Stratification challenges the assumption that colorectal cancer is unpredictable. Through hereditary panels, biomarker analysis, and molecular diagnostics, precision medicine identifies risk years before routine screening begins, shifting care from late detection to proactive prevention.

From Donation to Discovery: How Data, Diagnostics, and Equity Power Health Systems examines how blood donation, laboratory diagnostics, and precision data infrastructure translate individual acts into population-level intelligence, advancing equitable care, surveillance, and system-wide resilience.